Thousands to benefit from decision to subsidise eczema treatment

Sky News

23 January 2022 - Australians suffering from a severe form of eczema will save tens of thousands of dollars after a new listing on the Pharmaceutical Benefits Scheme.

Rinvoq reduces itching and flare-ups by blocking enzymes that create signals in the body's immune system, resulting in inflammation.

Read Sky News article

Michael Wonder

Posted by:

Michael Wonder